English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduThe University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. Recent developments at MD Anderson include a computer game that helps breast cancer survivors improve symptoms of peripheral neuropathy, a publicly available single-cell atlas of CD19 chimeric antigen receptor (CAR) T cells, new targets for TP53-mutant acute myeloid leukemia (AML), a preclinical target for preventing chemobrain, a blood test to help identify patients at higher risk of developing pancreatic cancer, and genomic insights to predict the risk of outcomes in patients with bone cancer.
Tag: Breast Cancer
New robot could help diagnose breast cancer early
A device has been created that could carry out Clinical Breast Examinations (CBE).
Susan G. Komen® Analysis Shows Many Breast Cancer Patients Struggle To Afford Basic Needs: Housing, Transportation, Utilities
Lower income breast cancer patients often struggle to afford life’s necessities such as housing, transportation and utilities due to direct and incidental costs related to their treatment, according to a new analysis by Susan G. Komen®.
Shorter course of radiation therapy is safe for patients with early-stage breast cancer who have undergone mastectomy and reconstruction
Researchers at Dana-Farber Brigham Cancer Center have found that a shorter course of radiation therapy after mastectomy and breast reconstruction surgery provides the same protection against breast cancer recurrence and equivalent physical side-effects but substantially reduces life disruption and financial burden for patients.
Short-course radiation as effective as standard treatment for patients who opt for breast reconstruction after mastectomy
In a first-of-its-kind study, people with breast cancer who underwent implant-based breast reconstruction immediately following a mastectomy reported that getting fewer, higher doses of radiation was just as effective as standard radiation, did not increase side effects and saved them time and money.
With Regular Screening, More Women Survive Breast Cancer
To mark Breast Cancer Awareness Month, the American Cancer Society highlights its guidelines encouraging average-risk women to begin regular screening mammograms at age 45, with the option to begin screening as early as age 40.
Palex and Inbiomotion introduce pioneering test to aid oncologists in predicting recurrence and survival rates in breast cancer patients
Spain is the first country in the world to have this technology
• Results showing the clinical utility of the test were published in
Lancet Oncology and the Journal of National Cancer Institute
• The test is now available to oncologists and pathologists and will
benefit an estimated 24,000 patients each year in Spain
A New AI Model Has Been Developed to Improve Accuracy of Breast Cancer Tumor Removal
Researchers in the UNC School of Medicine have developed an AI model that can predict whether or not cancerous tissue has been fully removed from the body during breast cancer surgery.
Susan G. Komen® To Host MORE THAN PINK Walk in Dallas this Fall
Susan G. Komen®, the world’s leading breast cancer organization, today announced it will host a MORE THAN PINK Walk in Dallas on Saturday, Oct. 21, 2023. The events will raise critical funds that support breast cancer patients, advance research and provide patient navigation services to better serve those impacted by the disease.
Researchers at Case Western Reserve, University Hospitals to assess effectiveness of novel MRI method for breast cancer patients
Researchers at Case Western Reserve University
(CWRU) and University Hospitals (UH) will study whether a new magnetic resonance imaging exam can predict how chemotherapy’s effectiveness for a woman with breast cancer based on a single round of treatment.
Susan G. Komen® To Host MORE THAN PINK Walk in Arkansas This Fall
Susan G. Komen®, the world’s leading breast cancer organization, today announced it will host a MORE THAN PINK Walk in Arkansas this fall. The Northwest Arkansas MORE THAN PINK Walk will take place on Saturday, Oct. 7, 2023.
Mayo Clinic study reveals proton beam therapy may shorten breast cancer treatment
In a randomized trial, published in The Lancet Oncology, Mayo Clinic Comprehensive Cancer Center researchers uncover evidence supporting a shorter treatment time for breast cancer patients.
Living Beyond Breast Cancer Provides Expert Patient Perspectives during Breast Cancer Awareness Month
This fall, Living Beyond Breast cancer, the national patient information and support organization, is providing expert patient perspectives on patients living with breast cancer. Connect with members of the LBBC community to discuss living with breast cancer, racial equity in breast cancer health, and body image and reconstruction.
Study Unlocks New Insight about Breast Cancer Risk
A new study led by a researcher at New York Institute of Technology provides insight that could change how scientists and clinicians understand genetic predisposition to breast cancer, a condition that affects one in eight U.S. women in her lifetime.
Cancer screenings have saved the U.S. at least $6.5 trillion, study estimates
Americans have gotten at least 12 million more years of life to live because of preventive cancer screenings they’ve gotten the past 25 years, a new study estimates. That adds up to at least $6.5 trillion in added economic impact, because of scans and tests that look for early signs of breast, colon, cervical and lung cancer in adults at the highest risk.
Canadian researchers find radiation not necessary for patients with low-risk breast cancer
Researchers from McMaster University, BC Cancer, Hamilton Heath Sciences, and the University of British Columbia have found some women with early-stage, low-risk breast cancer may not need radiotherapy after breast conserving surgery.
MD Anderson Research Highlights for August 16, 2023
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention.
Drinking alcohol not likely to increase risk of a breast cancer recurrence
A Kaiser Permanente study provides new information that may help oncologists answer one of the most common questions they hear from breast cancer survivors: Is it safe to drink alcohol?
Breast cancer overdiagnosis common among older women
A study of more than 50,000 women found that continued breast cancer screening after age 70 was associated with a greater incidence of cancer that likely would not have caused symptoms in the patient’s lifetime. These findings suggest that overdiagnosis may be common among older women who are diagnosed with breast cancer after screening. The study is published in Annals of Internal Medicine.
Easing Anxiousness with Experienced Breast Care
LifeBridge Health’s new Center for Breast Health at Pomona Square offers compassionate, full-service breast care for all those in need.
New grant seeks to parse how the variegated nature of human breast cancer tumors helps cancer cells resist treatment
The National Cancer Institute (NCI) has awarded a 5-year, $2.7 million grant to researchers at Sanford Burnham Prebys to investigate and elucidate the underlying cellular mechanisms that drive the most common form of breast cancer.
MD Anderson Research Highlights for August 2, 2023
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
Recent developments include a novel biomarker that may predict the aggressiveness of pancreatic cancer precursors, insights into the structure and function of a breast and ovarian cancer susceptibility gene, a new approach to overcoming treatment resistance in ovarian cancer, distinguishing features of young-onset rectal cancer, a biomarker and potential target for metastatic lung cancer, machine learning models to better predict outcomes of patients with mantle cell lymphoma (MCL), and a promising therapy for patients with relapsed/refractory MCL.
Study Uncovers Barriers to Mammography Screening Among Black Women
The study finds utilization of annual screening mammograms suboptimal among low-income Black women with several reported perceived and actual barriers. Most had a low breast cancer risk perception. Interestingly, participants perceived mammograms as very beneficial: 80 percent believed that ‘if breast cancer is found early, it’s likely that the cancer can be successfully treated;’ 90 percent indicated that ‘having a mammogram could help find breast cancer when it is first getting started.’
Susan G. Komen® Commends Introduction of Legislation to Remove Financial Barriers to Diagnostic Imaging
Susan G. Komen commends commends the introduction of the Access to Breast Cancer Diagnosis (ABCD) Act of 2023 in the U.S. House of Representatives and the U.S. Senate. The legislation would remove a significant financial barrier to people receiving medically necessary diagnostic and supplemental breast imaging.
Scientists make promising discovery in fight against breast cancer
Researchers from the University of Liverpool have created a biomedical compound that has the potential to stop the spread of breast cancer. A recently published paper details these early findings.
MD Anderson Research Highlights for July 19, 2023
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
Susan G. Komen® Launches A National Breast Cancer Research Registry
Susan G. Komen®, the world’s leading breast cancer organization has launched an innovative, cloud-based, research platform specifically for breast cancer patients and survivors to share their personal health data with Komen, where it will be used to accelerate breast cancer research and help discover the cures for breast cancer.
Sylvester Researchers, Collaborators Seek Answers to Prostate, Breast Cancer Among People of African Ancestry
Cancer Disparities: A new African Cancer Genome Registry at Sylvester Comprehensive Cancer Center in Miami seeks to find reasons for higher prostate and breast cancer rates in people of African ancestry. Dr. Sophia George, co-principal investigator, is available for interviews, as are two breast and prostate cancer study participants.
Breast cancer by age: Study reveals early mutations that predict patient outcomes
A study led by researchers at Sanford Burnham Prebys has found that in young women, certain genetic mutations are associated with treatment-resistant breast cancer.
Susan G. Komen® Urges Fifth Circuit to Protect Access to Preventive Services
Susan G. Komen® filed an amicus brief supporting the U.S. Department of Justice’s request that the Fifth Circuit Court of Appeals issue a stay in Braidwood v. Becerra.
June Tip Sheet from Sylvester Comprehensive Cancer Center
A world-renowned biochemist joins the Sylvester Cancer team, a global health leader strives to ensure more equitable cancer care, a recent study identifies disparities in federal cancer research funding, new targeted therapies for thyroid and other cancers are making surgery a secondary option for many patients, efforts to preserve women’s sexual health while they receive endocrine therapy for breast cancer, and more are highlighted in this month’s tip sheet from Sylvester Comprehensive Cancer Center.
Some breast cancer treatments may limit effectiveness of weight loss medications
Breast cancer medications, called aromatase inhibitors, may lessen the effect of weight loss drugs, according to a new study being presented Friday at ENDO 2023, the Endocrine Society’s annual meeting in Chicago, Ill.
Barriers to Breast Cancer-Screening in Vulnerable Populations
Women of racial and ethnic minorities experience challenges that hinder adherence to regular mammography screenings.
Race and Ethnicity Affect 21-Gene Recurrence Score, Overall Survival in Women with ER+ Breast Cancer
An observational cohort study out of Roswell Park Comprehensive Cancer Center demonstrates that race and ethnicity affect a woman’s 21-gene recurrence score, a tool used to determine risk of recurrence and distant metastasis in patients with early-stage, hormone-receptor-positive breast cancer. Based on the expression of 21 cancer-related genes detected in pre-treatment tumor specimens, recurrence score is used routinely in clinical care to identify patients who might benefit from chemotherapy as part of their treatment plan. Scores range from 0-100, with a score of 26 or higher indicating greater risk of recurrence and poorer overall survival.
Cancer discoveries could enhance immunotherapy, breast cancer care
Two new discoveries from the Dudley lab at UVA Cancer Center highlight the different roles of blood vessels in solid tumors – and the findings could help prevent breast cancer from spreading and enhance the effectiveness of one of the most important new cancer treatments in many years.
ASCO23: Sylvester Cancer Experts Available for Interviews on a Wide Range of Topics
In addition to presenting Sylvester Comprehensive Cancer Center research findings, Sylvester experts are available at ASCO to share perspectives on a wide variety of topics and studies ranging from breast cancer to sarcoma, prostate cancer, mesothelioma, melanoma, CNS tumors and more.
Statement on Passage of Diagnostic Imaging Legislation in Minnesota
Susan G. Komen thanked lawmakers in Minnesota for passing and Gov. Tim Walz for signing legislation that eliminates out-of-pocket costs for diagnostic and supplemental breast imaging.
Cancer screening recommendations are not keeping pace with diverse health needs of the individuals we have been entrusted to care for each day
The recommendation by the U.S. Preventive Services Task Force for women to be screened for breast cancer every other year starting at age 40 should be viewed as a starting point for a much bigger discussion, according to Dr. Brenda…
ASCO: Targeted therapy for early breast cancer, progress treating recurrent glioma, PSMA PET scan advances and more
Physicians and scientists from the UCLA Jonsson Comprehensive Cancer Center will discuss the latest research and clinical trial results on combination therapies for breast cancer, a potential new treatment for patients with recurrent glioma, and advances in PSMA PET guided radiotherapy for patients with prostate cancer, among other topics, at the American Society of Clinical Oncology’s annual meeting.
Breast Cancer Screening in Asian American & Pacific Islander Women in New Jersey
Recently, the United States Preventative Service Task Force released a draft recommendation statement on screening for breast cancer, recommending that all women get screened for breast cancer every other year starting at age 40. Rutgers Cancer Institute expert shares breast cancer data on the AAPI community.
How Breast Cancer Arises
At a glance:
Researchers trace the origin of certain breast cancers to genomic reshuffling — rearrangement of chromosomes — that activates cancer genes and ignites disease.
The finding offers a long-missing explanation for many cases of the disease that remain unexplained by the classical model of breast cancer development.
The study shows the sex hormone estrogen — thus far thought to be only a fuel for breast cancer growth — can directly cause tumor-driving genomic rearrangements.
UC San Diego Health Oncologist Addresses New Breast Cancer Screening Guidelines
The U.S. Preventive Services Task Force (USPSTF) has updated mammography screening guidelines for breast cancer detection to every other year beginning at age 40 instead of 50. This recommendation is based on new evidence of a rise in breast cancer…
Statement on Passage of Diagnostic and Supplemental Imaging Legislation in Tennessee
Susan G. Komen thanked Tennessee lawmakers and Governor Bill Lee for signing legislation into law that removes out-of-pocket costs for diagnostic and supplemental breast imaging.
University Hospitals Portage Medical Center Brings New Healthcare Investments to Community
University Hospitals Portage Medical Center has made a number of recent investments in various areas to better serve patients in the community. Throughout the next few months, the hospital will be opening a new Breast Health Center, renovating its Cath Lab, enhancing women’s health services, and making new improvements in nuclear medicine, imaging, and across its facilities.
New mammogram guidelines are a move in the right direction but not perfect, according to leading breast cancer radiologist
Linda Hovanessian Larsen, MD, a breast cancer radiologist with Keck Medicine of USC and the director of the Division of Breast Imaging at the Keck School of Medicine of USC, is available to talk about the new guidelines from the U.S.…
Change in breast density over time linked to cancer risk
Repeated mammograms contain data on changes in breast density over time that could help identify women at high risk of breast cancer and even reveal which breast is likely to be affected, according to a study by researchers at Washington University School of Medicine in St. Louis.
Susan G. Komen® Comments on Draft Recommendations to Begin Breast Cancer Screening at Age 40
Susan G. Komen is pleased to see that the USPSTF has taken into account more recent scientific-based evidence and believes women of average risk should begin breast cancer screening at age 40. However, Komen believes screening should be done every year to catch cancer as early as possible when outcomes are generally better and treatment costs less.
Change In Guidance: Women Should Be Screened For Breast Cancer Starting at 40, Ten Years Earlier Than Previously Advised
Women should begin getting regular mammograms to screen for breast cancer at age 40. That is new draft guidance from the United States Preventive Services Task Force.
ACR/SBI Statement on New USPSTF Breast Cancer Screening Recommendations
New USPSTF Breast Cancer Screening Recommendations are a step in the right direction. However, the American College of Radiology and Society of Breast Imaging urge the USPSTF to go further to recommend annual mammography screening for all average-risk women ages 40 and older.
New ACR Breast Cancer Screening Guidelines call for earlier and more-intensive screening for high-risk wome
New American College of Radiology® (ACR®) breast cancer screening guidelines now call for all women — particularly Black and Ashkenazi Jewish women — to have risk assessment by age 25 to determine if screening earlier than age 40 is needed.